title: Chemotherapy uptake and wait times in early-stage non-small-cell lung cancer.
abstract: BACKGROUND
  Treatment uptake and elapsed times along the care path have emerged as potential quality indicators for cancer care delivery. This retrospective study examined changes in adjuvant chemotherapy uptake and elapsed times along the care path for patients in 2005 and in 2007 who had early-stage non-small-cell lung cancer (nsclc) and who underwent curative-intent surgery in Nova Scotia, Canada.
  
  
  METHODS
  All patients who underwent curative-intent surgery for stages i-iii nsclc in the two years of interest were included. Logistic regression and general linear models were used to examine factors associated with chemotherapy uptake patterns and, at various resolutions (low, intermediate, high), elapsed times between all care events in the care path.
  
  
  RESULTS
  In the 223 patients who underwent curative-intent surgery (108 in 2005, 115 in 2007), several factors were associated with uptake patterns and elapsed times. Cohort year (2007 vs. 2005) was not associated with referral to medical oncology [odds ratio (or): 1.05; 95% confidence interval (ci): 0.51 to 2.15; p = 0.905], but it was associated with less treatment after referral (or: 0.34; 95% ci: 0.11 to 1.00; p = 0.057) and less overall uptake (or: 0.35; 95% ci: 0.13 to 0.95; p = 0.040). Patients were referred sooner to medical oncology in 2007 than in 2005 (21 days vs. 35 days, p = 0.008), but experienced longer waits between consultation and chemotherapy delivery (18 days vs. 7 days, p = 0.001).
  
  
  CONCLUSIONS
  Significant differences were observed in care patterns over time. Frequent monitoring of care patterns at high resolution may optimize insights into emerging trends within cancer care systems.
authors.affiliation: Division of Medical Oncology, Department of Medicine, QEII Health Sciences Centre, Halifax, NS.
authors.forename: S
authors.initials: S
authors.lastname: Gray
authors.forename: J
authors.initials: J
authors.lastname: Bu
authors.forename: N
authors.initials: N
authors.lastname: Saint-Jacques
authors.forename: D
authors.initials: D
authors.lastname: Rayson
authors.forename: T
authors.initials: T
authors.lastname: Younis
keywords: Non-small-cell lung cancer; adjuvant chemotherapy; elapsed times; treatment uptake; wait times